Loading clinical trials...

Stellate Ganglion Block with Lidocaine for the Treatment of COVID-19-Induced Parosmia | Clinical Trials | Clareo Health

RECRUITINGPhase 3NCT06055270

Stellate Ganglion Block with Lidocaine for the Treatment of COVID-19-Induced Parosmia

Chronic olfactory dysfunction, both hyposmia and parosmia, from the COVID-19 pandemic is a growing public health crisis, affecting up to 1.2 million people in the United States. Olfactory dysfunction ...

Lead sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Lanette Friesen-Waldner, Ph.D

CONTACT

5196466100 lanette.friesen-waldner@sjhc.london.on.ca

Cristian Dihel, MD

CONTACT

cristian.dihel@sjhc.london.on.ca

Related studies

RECRUITINGNA

Olfactory Training As a Treatment for Olfactory Dysfunction Post COVID-19

NCT05384561 · Hyposmia, COVID-19, and more

COMPLETEDPhase 1/2

Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction

NCT05445921 · Anosmia, Hyposmia, and more

WITHDRAWNPhase 2

Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia

NCT05216614 · COVID-19, Olfactory Disorder, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 23, 2024Terms

Trial snapshot

StatusRECRUITING

PhasePHASE3

Enrollment44

Start dateFeb 2024

Last updatedOct 23, 2024

Condition

Parosmia

Locations shown

St. Joseph's Hospital London

London, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 23, 2024Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions